SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer. Kenger currently serves as the SVP of Design at Hims & Hers and has been at the company since its founding. “ I started at Hims & Hers seven years ago with a commitment to deliver a truly thoughtful, accessible, personalized experience to every person who interacts with our brand,” ...

Chinnapong/iStock via Getty ImagesIntro Hims & Hers Health (NYSE:HIMS) is a pioneering player in the telehealth sector that has been making waves in the healthcare industry. Operating in the vast and rapidly expanding telehealth market, we believe HIMS is well-positioned as an early-stage disruptor with a unique approach to providing accessible healthcare solutions. The company generates revenue through its innovative platform, offering a range of telehealth services, including consultations, prescripti ...

Long-term investing is the key to sustainable returns in the stock market because it smooths out near-term volatility and gives a company time to deliver on its growth or profit potential. This strategy can be particularly useful for smaller growth stocks like Hims & Hers (HIMS -2.17%).Let's discuss what the next five years could hold for this unique company as it scales its business model and swings toward sustainable profitability. What is Hims & Hers?Founded in 2017, Hims & Hers is a telemedicine company ...

SAN FRANCISCO & HARTFORD, Conn.--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services. The collaboration provides patients with an enhanced and connected healthcare experience when they need care outside the Hims & Hers platform. Licensed medical providers on the platform wi ...

Hims & Hers Health, Inc. (HIMS) shares ended the last trading session 8.3% higher at $9.64. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.1% gain over the past four weeks.Hims & Hers Health scored a strong price increase, on investors’ optimism driven by the company’s newly launched Weight Loss program — a comprehensive and customizable clinical approach developed with expert insights to help people achieve the ...

People can and should consider what Wall Street analysts say about a stock. After all, these analysts are the professionals of the investing world and are compensated very well for their research and opinions.But that doesn't mean that they're always right. In fact, it looks like they may have made a jaw-dropping mistake with Hims & Hers Health (HIMS -1.44%), an up-and-coming telehealth company that doesn't have the mainstream attention bigger companies have.The evidence overwhelmingly points to the company ...

Financial Results Third Quarter2023 2 This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "assume," "may," "will," "likely," "potential," "projects," "predicts," "continue," "goal," ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2023 Earnings Conference Call November 6, 2023 5:00 PM ET Company Participants Alice Lopatto - VP, IR Andrew Dudum - Co-Founder, Chairman & CEO Yemi Okupe - CFO Conference Call Participants Glen Santangelo - Jefferies Daniel Grosslight - Citigroup Jack Wallace - Guggenheim Securities Jailendra Singh - Truist Securities Allen Lutz - Bank of America Merrill Lynch George Hill - Deutsche Bank Operator Ladies and gentlemen, thank you for standing by. At this time, I would ...

Financial Performance - Revenue for Q3 2023 reached $226.7 million, a 56.5% increase from $144.8 million in Q3 2022[20] - Gross profit for Q3 2023 was $187.3 million, compared to $114.5 million in Q3 2022, reflecting a 63.5% increase[20] - Total operating expenses for Q3 2023 were $195.9 million, up from $134.4 million in Q3 2022, representing a 45.7% increase[20] - Net loss for Q3 2023 was $7.6 million, an improvement from a net loss of $18.8 million in Q3 2022[20] - Revenue for the nine months ended September 30, 2023, was $625.4 million, compared to $359.7 million for the same period in 2022[138] - Adjusted EBITDA for Q3 2023 was $12.25 million, compared to a loss of $6.1 million in Q3 2022[138] - Adjusted EBITDA margin for Q3 2023 was 5%, improving from a negative margin of 4% in Q3 2022[138] Cash and Assets - Cash and cash equivalents increased to $58.0 million as of September 30, 2023, up from $46.8 million at the end of 2022[18] - Total assets grew to $413.9 million as of September 30, 2023, compared to $366.3 million at the end of 2022[18] - Total stockholders' equity increased to $328.6 million as of September 30, 2023, from $311.7 million at the end of 2022[18] - The total cash, cash equivalents, and restricted cash at the end of the period was $58,852 thousand, slightly up from $58,820 thousand at the end of September 2022[27] - The company had total short-term investments of $154.5 million as of September 30, 2023, compared to $132.9 million as of December 31, 2022[56] Expenses - Marketing expenses for Q3 2023 were $116.1 million, a 48.0% increase from $78.5 million in Q3 2022[20] - Customer acquisition costs reached $98.6 million in Q3 2023, compared to $67.3 million in Q3 2022, reflecting a strategic investment in marketing[159] - Cost of revenue for Q3 2023 was $39.4 million, a 30% increase from $30.4 million in Q3 2022, primarily due to rising shipping and medical consultation costs[157] - Operations and support expenses rose to $31.6 million in Q3 2023, a 45% increase from $21.8 million in Q3 2022[146] - Technology and development expenses increased to $12.3 million in Q3 2023, a 54% rise from $8.0 million in Q3 2022[147] - General and administrative expenses were $35.9 million in Q3 2023, up 37% from $26.2 million in Q3 2022[149] Subscriber and Revenue Growth - The Company reported 1,426 Subscribers at the end of September 30, 2023, a growth of 510 Subscribers, or 56%, from 916 Subscribers in the same period of 2022[124] - For the three months ended September 30, 2023, the Company generated $219.7 million in Online Revenue, an increase of $79.9 million, or 57%, compared to $139.8 million for the same period in 2022[124] - For the nine months ended September 30, 2023, Online Revenue reached $605.0 million, up $263.7 million, or 77%, from $341.3 million in the same period of 2022[124] - Net Orders for the three months ended September 30, 2023, totaled 2,222, representing an increase of 547 orders, or 33%, from 1,675 in the same period of 2022[124] - Average Order Value (AOV) for the three months ended September 30, 2023, was $99, an increase of $16, or 19%, compared to $83 in the same period of 2022[124] Stock-Based Compensation - Stock-based compensation increased to $48,289 thousand in 2023 from $30,467 thousand in 2022, reflecting a 58.6% rise[27] - The total stock-based compensation expense for the nine months ended September 30, 2023, was $48.3 million, compared to $30.5 million for the same period in 2022, representing a year-over-year increase of 58.7%[100] - The Company recognized stock-based compensation expense of $17.3 million for the three months ended September 30, 2023, compared to $11.0 million for the same period in 2022, indicating a 57.5% increase[100] Future Outlook and Strategy - The company plans to continue investing in fulfillment and operating capabilities, including expanding facilities over the next 12 months[132] - Future growth is expected to come from expanding into new health and wellness categories, requiring financial investments in marketing and operational capabilities[134] - The company emphasizes the importance of customer retention for revenue generation, with a focus on maintaining long-term revenue retention from Subscribers[131] - The company anticipates that marketing initiatives may become increasingly difficult and expensive due to the competitive nature of the market[211] Risks and Challenges - The company has encountered significant risks and uncertainties frequently experienced by new and growing companies in rapidly changing and heavily regulated industries[196] - Evolving government regulations may require increased costs or adversely affect the company's results of operations[197] - The company faces competition from large, well-established healthcare providers and technology companies, which may impact its ability to compete effectively[194] - Negative publicity regarding telehealth and customer confidentiality could limit market acceptance of the company's business model and services[216]

Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Alice Lopatto - Vice President, Investor Relations Andrew Dudum - Co-Founder & Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Daniel Grosslight - Citi Jack Wallace - Guggenheim Securities Michael Cherny - Bank of America Glen Santangelo - Jefferies Jungwon Kim - Cowen Jonathan Young - Credit Suisse Jailendra Singh - Truist Securities George Hill - De ...